个人中心 - 老虎社区

jamesrayan

IP属地：未知

帖子 · 5帖子 · 5
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- jamesrayanjamesrayan
  ·2021-07-24
  to the moon
  非常抱歉，此主贴已删除
  711 1
  4
  分享
  举报
- jamesrayanjamesrayan
  ·2021-07-21
  nice
  Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook
  
  Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook
  835 1
  3
  分享
  举报
- jamesrayanjamesrayan
  ·2021-07-21
  👍🏻
  EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection
  FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o
  EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection
  300 评论
  3
  分享
  举报
- jamesrayanjamesrayan
  ·2021-06-28
  buy buy buy
  Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M
  Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth
  Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M
  299 评论
  3
  分享
  举报
- jamesrayanjamesrayan
  ·2021-02-18
  Cool
  非常抱歉，此主贴已删除
  432 评论
  点赞
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3572672756847501","uuid":"3572672756847501","gmtCreate":1609579702418,"gmtModify":1624862867179,"name":"jamesrayan","pinyin":"jamesrayan","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":1,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.86%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":174802757,"gmtCreate":1627088973479,"gmtModify":1633768134196,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"to the moon","listText":"to the moon","text":"to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/174802757","repostId":"2153980423","repostType":4,"isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176117712,"gmtCreate":1626871356236,"gmtModify":1633770266861,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/176117712","repostId":"2153645824","repostType":4,"repost":{"id":"2153645824","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626870335,"share":"https://www.laohu8.com/m/news/2153645824?lang=&edition=full","pubTime":"2021-07-21 20:25","market":"hk","language":"en","title":"Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2153645824","media":"Benzinga","summary":"\n","content":"<ul>\n <li><b><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> Co</b>&nbsp;reported second-quarter&nbsp;FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. <a href=\"https://laohu8.com/S/UNT\">Unit</a> case volume grew 18% in the quarter.</li>\n <li>Revenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.</li>\n <li>Revenue performance included 26% growth in concentrate sales and 11% growth in price/mix.</li>\n <li>The operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.</li>\n <li>Cash flow generated from operating activities was $5.5 billion.</li>\n <li>Comparable EPS of $0.68 beat the analyst consensus of $0.55.</li>\n <li>\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.</li>\n <li><b>Outlook</b>: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.</li>\n <li>It expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.</li>\n <li><b>Price action:</b>&nbsp;KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/3d370c35873b63d62ebec60598ee7d15\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoca-Cola Shares Gain On Strong Q2 Earnings, Raised FY21 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-21 20:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/KO\">Coca-Cola</a> Co</b>&nbsp;reported second-quarter&nbsp;FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. <a href=\"https://laohu8.com/S/UNT\">Unit</a> case volume grew 18% in the quarter.</li>\n <li>Revenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.</li>\n <li>Revenue performance included 26% growth in concentrate sales and 11% growth in price/mix.</li>\n <li>The operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.</li>\n <li>Cash flow generated from operating activities was $5.5 billion.</li>\n <li>Comparable EPS of $0.68 beat the analyst consensus of $0.55.</li>\n <li>\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.</li>\n <li><b>Outlook</b>: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.</li>\n <li>It expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.</li>\n <li><b>Price action:</b>&nbsp;KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/3d370c35873b63d62ebec60598ee7d15\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","KO":"可口可乐"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153645824","content_text":"Coca-Cola Co reported second-quarter FY21 net revenue growth of 41.3% year-on-year to $10.1 billion, beating the analyst consensus of $9.25 billion. Unit case volume grew 18% in the quarter.\nRevenue growth was driven by the ongoing recovery in markets as the coronavirus-related uncertainty is starting to decrease.\nRevenue performance included 26% growth in concentrate sales and 11% growth in price/mix.\nThe operating margin was 29.8%, while the comparable operating margin improved to 31.7%. Operating income for the quarter rose 52% to $3.02 billion.\nCash flow generated from operating activities was $5.5 billion.\nComparable EPS of $0.68 beat the analyst consensus of $0.55.\n\"Our results in the second quarter show how our business is rebounding faster than the overall economic recovery, led by our accelerated transformation,\" said CEO James Quincey.\nOutlook: Coca-Cola sees FY21 organic revenue growth of 12% - 14%, versus prior outlook for of high single digits growth.\nIt expects FY21 comparable EPS growth of 13% - 15%, versus previous guidance for percentage growth of high single digits to low double digits versus $1.95 in 2020. The growth expectations exceed analyst FY21 EPS consensus of $2.18.\nPrice action: KO shares are trading higher by 2.10% at $57.00 in premarket on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":835,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176117854,"gmtCreate":1626871321678,"gmtModify":1633770267410,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176117854","repostId":"1121414767","repostType":4,"repost":{"id":"1121414767","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626871035,"share":"https://www.laohu8.com/m/news/1121414767?lang=&edition=full","pubTime":"2021-07-21 20:37","market":"us","language":"en","title":"EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection","url":"https://stock-news.laohu8.com/highlight/detail?id=1121414767","media":"Benzinga","summary":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday o","content":"<p>Former<b>PepsiCo Inc</b>&nbsp;PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about&nbsp;<b>Celularity Inc</b>CELUMonday on&nbsp;Benzinga's YouTube show \"Power Hour.\"</p>\n<p>Celularity founder and CEO<b>Robert Harini</b>appeared on&nbsp;\"Power Hour\"&nbsp;for an exclusive interview Tuesday.</p>\n<p>Celularity went public via special purpose acquisition company&nbsp;<a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p>\n<p>Celularity focuses on delivering&nbsp;cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p>\n<p>Sculley is a&nbsp;founding director and vice chairman of the board at Cellularity.</p>\n<p>Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley,&nbsp;an award he received&nbsp;from<b>Pope Francis</b>and more.</p>\n<p><b>Key Highlights:</b></p>\n<ul>\n <li>The human placenta is \"nature's stem cell factory.\"&nbsp;Celularity uses&nbsp;the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li>\n <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its&nbsp;deep interest in biological science and the health care industry.</li>\n <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging.&nbsp;Cellular biology is \"here to stay.\"</li>\n <li>Harini developed his passion after being&nbsp;intrigued by the possibility for&nbsp;stem cells to be used as&nbsp;a tool for restoring function in a damaged brain.</li>\n <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li>\n</ul>\n<p><b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEXCLUSIVE: Celularity's CEO On 'One-Size-Fits-All' Product, Palantir Connection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-21 20:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Former<b>PepsiCo Inc</b>&nbsp;PEPpresident and<b>Apple Inc</b>AAPLCEO<b>John Sculley</b>raved about&nbsp;<b>Celularity Inc</b>CELUMonday on&nbsp;Benzinga's YouTube show \"Power Hour.\"</p>\n<p>Celularity founder and CEO<b>Robert Harini</b>appeared on&nbsp;\"Power Hour\"&nbsp;for an exclusive interview Tuesday.</p>\n<p>Celularity went public via special purpose acquisition company&nbsp;<a href=\"https://laohu8.com/S/GXGX\">GX Acquisition</a> Corp. on July 16.</p>\n<p>Celularity focuses on delivering&nbsp;cellular medicines derived from the postpartum human placenta, Harini told Benzinga.</p>\n<p>Sculley is a&nbsp;founding director and vice chairman of the board at Cellularity.</p>\n<p>Harini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley,&nbsp;an award he received&nbsp;from<b>Pope Francis</b>and more.</p>\n<p><b>Key Highlights:</b></p>\n<ul>\n <li>The human placenta is \"nature's stem cell factory.\"&nbsp;Celularity uses&nbsp;the placenta to produce a product that is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a>-size-fits-all.\"</li>\n <li>Celularity uses<b>Palantir Technologies Inc</b>PLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its&nbsp;deep interest in biological science and the health care industry.</li>\n <li>One great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging.&nbsp;Cellular biology is \"here to stay.\"</li>\n <li>Harini developed his passion after being&nbsp;intrigued by the possibility for&nbsp;stem cells to be used as&nbsp;a tool for restoring function in a damaged brain.</li>\n <li>He believes Celularity's future products will have the quality and economics to help lead the industry.</li>\n</ul>\n<p><b>CELU Price Action:</b>Celularity shares gained 4.05% Tuesday, closing at $21.85.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121414767","content_text":"FormerPepsiCo Inc PEPpresident andApple IncAAPLCEOJohn Sculleyraved about Celularity IncCELUMonday on Benzinga's YouTube show \"Power Hour.\"\nCelularity founder and CEORobert Hariniappeared on \"Power Hour\" for an exclusive interview Tuesday.\nCelularity went public via special purpose acquisition company GX Acquisition Corp. on July 16.\nCelularity focuses on delivering cellular medicines derived from the postpartum human placenta, Harini told Benzinga.\nSculley is a founding director and vice chairman of the board at Cellularity.\nHarini said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Harini went on to talk more about Sculley, an award he received fromPope Francisand more.\nKey Highlights:\n\nThe human placenta is \"nature's stem cell factory.\" Celularity uses the placenta to produce a product that is \"one-size-fits-all.\"\nCelularity usesPalantir Technologies IncPLTR 0.05%to enhance the quality of its products. Palantir sought out the partnership because of its deep interest in biological science and the health care industry.\nOne great future opportunity will be to find ways to mitigate the degenerative changes that occur with aging. Cellular biology is \"here to stay.\"\nHarini developed his passion after being intrigued by the possibility for stem cells to be used as a tool for restoring function in a damaged brain.\nHe believes Celularity's future products will have the quality and economics to help lead the industry.\n\nCELU Price Action:Celularity shares gained 4.05% Tuesday, closing at $21.85.","news_type":1},"isVote":1,"tweetType":1,"viewCount":300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127431428,"gmtCreate":1624861829964,"gmtModify":1633947812972,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"buy buy buy","listText":"buy buy buy","text":"buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127431428","repostId":"1110515408","repostType":4,"repost":{"id":"1110515408","kind":"news","pubTimestamp":1624859565,"share":"https://www.laohu8.com/m/news/1110515408?lang=&edition=full","pubTime":"2021-06-28 13:52","market":"us","language":"en","title":"Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M","url":"https://stock-news.laohu8.com/highlight/detail?id=1110515408","media":"Benzinga","summary":"Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth","content":"<p>Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in&nbsp;<b>UiPath Inc</b>(NYSE:PATH).</p>\n<p>Shares of the New York-based software automation company closed 1.04% higher at $69.77 on Friday.</p>\n<p>The investment firm made the purchase via&nbsp;the&nbsp;<b>ArkGenomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>Ark owns PATH shares via all of its six active ETFs. On a consolidated basis, the Wood-led firm now holds over 10 million shares, worth around $670 million in UiPath.</p>\n<p>The products of the Bucharest, Romania-based&nbsp;software companyare used by organizations to help efficiently automate their various business processes. PATH closed 5.34% higher on Wednesday, giving the company a market valuation of $35.8 billion.</p>\n<p>Some of the other key Ark Invest sells on Friday include&nbsp;<b>Pluristem Therapeutics</b>(NASDAQ:PSTI) and buys include&nbsp;<b>Quantum-Si Inc</b>(NASDAQ:QSI).</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Buys Another $9.6M In Uipath, Raises Stake In Automation Company To $670M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-28 13:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH).\nShares of the New York-based software automation ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PATH":"UiPath","QSI":"Quantum-Si Inc."},"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/21/06/21737470/cathie-wood-buys-another-9-6m-in-uipath-raises-stake-in-automation-company-to-670m","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110515408","content_text":"Cathie Wood-led Ark Investment Management on Friday snapped up 136,859 shares, estimated to be worth about $9.55 million, in UiPath Inc(NYSE:PATH).\nShares of the New York-based software automation company closed 1.04% higher at $69.77 on Friday.\nThe investment firm made the purchase via the ArkGenomic Revolution ETF(BATS:ARKG).\nArk owns PATH shares via all of its six active ETFs. On a consolidated basis, the Wood-led firm now holds over 10 million shares, worth around $670 million in UiPath.\nThe products of the Bucharest, Romania-based software companyare used by organizations to help efficiently automate their various business processes. PATH closed 5.34% higher on Wednesday, giving the company a market valuation of $35.8 billion.\nSome of the other key Ark Invest sells on Friday include Pluristem Therapeutics(NASDAQ:PSTI) and buys include Quantum-Si Inc(NASDAQ:QSI).","news_type":1},"isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384974986,"gmtCreate":1613611005045,"gmtModify":1634552959894,"author":{"id":"3572672756847501","authorId":"3572672756847501","name":"jamesrayan","avatar":"https://static.tigerbbs.com/9812c2079a10e021785128fd39823c51","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572672756847501","authorIdStr":"3572672756847501"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/384974986","repostId":"1109567373","repostType":4,"isVote":1,"tweetType":1,"viewCount":432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}